Mellitus' Debt - II Round

Mellitus raised a round of funding on September 28, 2015.

Mellitus is developing a novel in vitro diagnostic test for the measurement of Glycated CD59 (GCD59) with potential clinical utility in screening, diagnosis and monitoring of diabetes, stratification …

Articles about Mellitus' Debt - II Round: